European Commission Offers New Q&A on Biosimilars By Anna Jurczynska | February 6, 2017 Posted in Recent News and tagged biosimilars, EU, Europe, European Commission ← Bangladesh: Partnership OpportunitiesFirst Belgian Medical Affairs Day →